Journey Clinical

What Journey Clinical does

Journey Clinical is a US-based digital health platform founded in 2021 that operates the largest network of ketamine-assisted psychotherapy (KAP) providers in the country, connecting approximately 3,000 licensed therapist practices across 30 states with patients seeking treatment-resistant mental health care. The platform delivers a collaborative care model that pairs in-house psychiatrists and psychiatric nurse practitioners (who prescribe sublingual ketamine) with independently licensed therapists who run preparation, in-session support, and integration sessions. The underlying technology is a HIPAA-compliant patient portal (my.journeyclinical.com) supporting therapist matching by insurance, state, and specialty; insurance benefits verification and in-network billing with major payers (Aetna, Anthem, BCBS, Cigna, UnitedHealthcare, Enthea, Harvard Pilgrim, Moda, Tufts); and clinical outcome monitoring across 1M+ hours of KAP delivered.

The company operates four product lines: (1) the core KAP program, billed in two installments totaling roughly $720 self-pay for an 8-session course ($362 for intake plus first two doses; $358 for follow-up plus six additional doses); (2) Spravato (FDA-approved esketamine nasal spray) administration at in-person clinic locations; (3) standalone psychiatric medication management ($250 initial, $150 monthly); and (4) clinical trial enrollment. Revenue is generated through patient self-pay and insurance reimbursement for medical services, plus recurring membership fees from therapist network participants. Strategic priorities include deepening insurance in-network coverage, expanding the therapist network to remaining states, and positioning as the primary delivery operator for Compass Pathways' COMP360 psilocybin therapy upon FDA approval.

Name

Journey Clinical

Legal name

Journey Clinical, Inc.

Website

https://journeyclinical.com

Company type

Private

Founded year

2021

Operating status

Operating

Headcount range

11–50 employees

Short description

Journey Clinical operates the largest US network of ketamine-assisted psychotherapy providers, connecting approximately 3,000 licensed therapist practices across 30 states with patients seeking treatment for depression, anxiety, PTSD, and related mental health conditions.

Ownership category

akta.pro rank

Product category

Psychedelic-Assisted Therapy Services

NAICS

Offices of Physicians, Mental Health Specialists (621112), Outpatient Mental Health and Substance Abuse Centers (62142), Outpatient Mental Health and Substance Abuse Centers (621420)

SIC

Services-Specialty Outpatient Facilities, Nec (8093), Services-Offices & Clinics Of Doctors Of Medicine (8011)

akta.pro primary industry

Psychiatry & Medication Management Platforms (HLALAEAB)

akta.pro secondary industry

Specialty Pharmacy & Complex Therapy Management Platforms (HLACAKAG)

Keywords

• Ketamine-assisted psychotherapy
• Psychedelic-assisted therapy
• Mental health treatment
• Psychiatric medication management
• Esketamine treatment

Headquarters

HQ city

New York

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2B and B2C

Offering type

Services

Cost components

Personnel, Operations, Marketing or Sales, Technology or R&D, Supply Chain, Others

Revenue model

1. Medical Consultations and Ketamine Prescriptions: Journey Clinical bills patients for medical appointments with their in-house medical team (psychiatrists and psychiatric nurse practitioners) and ketamine medication. Payments are made in two installments: first payment covers intake evaluation and first 2 doses ($362 self-pay/$112 with insurance), second payment covers follow-up and 6 additional doses ($358 self-pay/$208 with insurance).
2. Therapist Network Membership: Licensed mental health professionals pay monthly membership fees to join Journey Clinical's network and access platform services, training resources, and connection to medical prescribers. Fees are specified in individual quote documents.
3. Spravato Treatment: FDA-approved esketamine nasal spray (Spravato) treatment for treatment-resistant depression, administered in-clinic with insurance coverage, offered as low as $10 per session through the withMe rebate program.
4. Psychiatric Medication Management: Standalone psychiatric medication management services for patients not pursuing KAP, with initial appointments at $250 and monthly follow-ups at $150 (plus medication costs), with partial insurance coverage available.

Pricing tiers

Go-to-market motion3 records

Distribution channels5 records

Marketing channels7 records

Core offering

Journey Clinical operates a psychedelic-assisted psychotherapy platform that connects patients seeking ketamine-assisted psychotherapy (KAP) with a national network of licensed, KAP-trained therapists. The platform coordinates medical prescriptions and dosing by in-house psychiatrists and nurse practitioners, then pairs treatment with structured preparation, in-session support, and post-dose integration therapy delivered by member therapists. It also offers FDA-approved Spravato® (esketamine) treatment, standalone psychiatric medication management, and clinical trial enrollment.

Product overview

Journey Clinical operates as a multi-service psychedelic-assisted psychotherapy platform offering four distinct but related offerings. The core product is Ketamine-Assisted Psychotherapy (KAP), which combines sublingual ketamine prescriptions with therapist-led preparation, dosing, and integration sessions through a collaborative care model pairing licensed psychotherapists with in-house medical prescribers. The platform also offers Spravato® (FDA-approved esketamine nasal spray) for treatment-resistant depression, standalone Psychiatric Medication Management for patients not pursuing KAP, and Clinical Trials enrollment for research participation. The platform connects patients with a network of over 3,000 KAP-trained therapists across 26 states, with insurance billing handled through in-network providers and a HIPAA-compliant patient portal for scheduling, medical records, and outcomes tracking.

Differentiator

Problem solved

Functional benefit

Products and services

• Ketamine-Assisted Psychotherapy (KAP) A psychedelic-assisted psychotherapy modality combining medically supervised sublingual ketamine dosing with structured preparation, in-session support, and post-dose integration therapy delivered by licensed KAP-trained psychotherapists in a collaborative care model. Designed for adults with treatment-resistant depression, anxiety, PTSD, trauma, OCD, and eating disorders across 26 states.
• Spravato® (esketamine nasal spray) FDA-approved intranasal esketamine treatment for adults with treatment-resistant depression or major depressive disorder with suicidal ideation, administered under clinical supervision at Journey Clinical's certified in-person clinic locations.
• Psychiatric Medication Management Standalone psychiatric medication management service offering initial medical intake, personalized treatment planning, ongoing medical oversight, and outcome monitoring by Journey Clinical's in-house medical team of psychiatrists and nurse practitioners. Available for patients who do not pursue KAP.
• Clinical Trials Enrollment Access to clinical trial enrollment for eligible patients, facilitated through a dedicated intake form on the platform and supported by the 2024 Compass Pathways research collaboration to deliver COMP360 psilocybin for treatment-resistant depression.
• Therapist Network Membership Monthly membership program for licensed mental health professionals providing KAP training (Fluence-designed), peer consultation groups, prescribing partnerships with Journey Clinical's in-house medical team, and access to platform tools to deliver KAP to their clients.

Quantifiable outcome

• 87% of patients experience improvement in anxiety and depression clinical scales after completing a full course of KAP treatment
• +4 more outcomes

Named customers4 records

Segments3 records

Ideal customer profiles3 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature5 records

Partnerships

Four partnerships are on record, tiered core and minor.

• Compass PathwayscoreStrategic or Co-development Partner · 1 January 2024Journey Clinical entered a 2024 research collaboration with Compass Pathways to support scalable delivery of COMP360 psilocybin treatment for treatment-resistant depression. COMP360 has FDA Breakthrough Therapy designation and is currently in Phase 3 trials. The partnership positions Journey Clinical as the primary operator prepared to deliver psilocybin treatments upon FDA approval.
• OptioRx/Braun PharmaCare Compounding PharmacycoreTechnology or IntegrationOptioRx is Journey Clinical's main compounding pharmacy partner, located in Chicago, IL. The pharmacy prepares and ships ketamine medications (rapid dissolving tablets or wax-based troches) directly to patient homes for use during KAP treatment sessions.
• FluenceminorStrategic or Co-development PartnerJourney Clinical provides access to Fluence-designed online education for therapists in its network, including KAP training and professional development resources. Fluence is a recognized provider of psychedelic therapy training and education.
• Spravato (Janssen/Johnson & Johnson)coreOEM/ Whitelabel/ Licensing PartnerJourney Clinical offers Spravato (esketamine nasal spray), the only FDA-approved ketamine-based treatment for treatment-resistant depression, at its clinic locations. Spravato is covered by most major insurance plans with the withMe rebate program reducing costs to as low as $10 per session.

Scale indicators9 records

Recent moves6 records

Expansion highlights6 records

Direct peers

• Mindbloom: At-home ketamine therapy provider offering medically supervised ketamine sessions combined with therapist integration. Directly competes with Journey Clinical in the at-home KAP category.
• Cerebral: Telehealth mental health platform providing psychiatric evaluation and medication management, with overlapping patient segments and treatment modalities including depression and anxiety care.
• Klarity: Telehealth psychiatry and medication management provider for ADHD, anxiety, and depression with insurance coverage — directly comparable in collaborative online psychiatry plus therapy delivery.
• Nue Life: Ketamine-assisted therapy platform combining psychedelic treatment with integration coaching and therapist support; competes in the same ketamine-plus-therapy category with at-home protocols.
• Innerwell: Virtual ketamine-assisted psychotherapy provider pairing patients with psychiatrists and therapists for at-home KAP treatment; directly overlapping service offering and target patient population.
• Alma: Therapist network platform with insurance credentialing, billing, and referrals — comparable in building a two-sided therapist-plus-patient marketplace with insurance integration, though without the ketamine medical component.
• Headway: Therapist platform that handles insurance credentialing, billing, and patient referrals for mental health practices; similar in-network infrastructure and therapist-side value proposition as Journey Clinical's therapist network.

Broad incumbents

• BetterHelp: Largest consumer telehealth therapy platform; broader psychotherapy marketplace with overlapping mental health patient acquisition, though it does not offer ketamine or psychiatric medication management.
• Talkspace: Public telehealth therapy and psychiatry platform with insurance coverage; broader incumbent that overlaps in online therapy and psychiatric medication management without ketamine specialization.
• Hims & Hers Health: Public telehealth consumer brand that has expanded into mental health treatment including anxiety and depression; broad incumbent that could enter adjacent psychedelic-assisted therapy at scale.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks6 records

Key highlights7 records

Customer concentration

• Xx.com/journeyclinical
• Facebookfacebook.com/journeyclinical
• LinkedInlinkedin.com/company/journey-clinical

Compliance1 record

Revenue estimate

Valuation estimate

Number of profiles

Profiles4 records

Funding overview

Funding rounds7 records

Investors16 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Journey Clinical